BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
-9.09%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$17.4B
AUM Growth
+$17.4B
(-15%)
Cap. Flow
+$303M
Cap. Flow
% of AUM
1.74%
Top 10 Holdings %
Top 10 Hldgs %
85.01%
Holding
123
New
2
Increased
15
Reduced
4
Closed
3
Top Buys
| 1 |
Incyte
INCY
|
$201M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$31.5M |
| 3 |
TSVT
2seventy bio
TSVT
|
$21M |
| 4 |
Replimune Group
REPL
|
$17.3M |
| 5 |
Travere Therapeutics
TVTX
|
$16.3M |
Top Sells
| 1 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$17.9M |
| 2 |
Legend Biotech
LEGN
|
$17.4M |
| 3 |
OPT
Opthea Limited American Depositary Shares
OPT
|
$3.43M |
| 4 |
ALBO
Albireo Pharma, Inc. Common Stock
ALBO
|
$2.43M |
| 5 |
GMDA
Gamida Cell Ltd. Ordinary Shares
GMDA
|
$1.55M |
Sector Composition
| 1 | Healthcare | 98.92% |
